. Author manuscript; available in PMC: 2018 Jan 11.

Published in final edited form as: Cell Rep. 2017 Dec 19;21(12):3458–3470. doi: 10.1016/j.celrep.2017.11.075

Table 1.

Clinical Characteristics of Subjects in Designated Groups

Status	No. of Subjects	Time on ART (Months)^a	Viral load RNA (Copies/mL)^a	Log Viral Load^a	CD4 Count (Cells/µL)^a	Sex (M/F)	Age (Years)^a	PBMCs/LNMCs (Matched)	Sample Origin
HIV⁻	41	N/A	N/A	N/A	1,319 (1,267–1,371), 2	15/18	38 (17–86), 33	23/20 (2)	Ohio (16), Mexico (8), Pennsylvania (15), and Greece (2)
Chronic	27	N/A	56,009 (1,439–1,387,603), 27	4.75 (3.16–6.14), 27	523 (142–1,130), 27	25/2	31 (20–62), 27	22/25 (20)	Mexico (27)
Chronic, ART	17	7 (1–108), 15	93 (20–7,103), 16	1.96 (1.6–3.9), 15	301 (199–834), 17	15/2	32 (22–51), 16	16/16 (15)	Mexico (15) and Pennsylvania (2)

N/A, not applicable.

Data are presented as median (range), number of subjects.